BETA: Please send your feedback!
Edge Therapeutics
EDGE:NAS
Biotechnology
$0
SMALL cap
$0.50
(0.00%)
0.39%
since start of 2019
-0.38
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2009
Edge Therapeutics, Inc. operates as biotechnology company which develops therapies. engages in the discovery, development, and commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions for which limited or no current therapies exist. It develops the Precisa Platform of EG-1962 and the EG-1964 treatments. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Albert N. Marchio, II, MBA | CFO, Chief Accounting & Administrative Officer | Male |
| Sol J. Barer, PhD | Chairman | Male |
| W. Bradford Middlekauff | Secretary, Senior Vice President & General Counsel | Male |
| Gregory W. Gin | Investor Relations Officer | Male |
| Brian A. Leuthner, MBA | President, Chief Executive Officer & Director | Male |
| Robert Loch Macdonald, PhD | Director & Chief Scientific Officer | Male |
| Carl J. Soranno | Founder | Male |
| Herbert J. Faleck, MD | Chief Medical Officer | Male |
| Daniel Brennan, MBA | Chief Operating Officer | Male |
| Renu Vaish | Vice President-Global Regulatory Affairs | Female |
| Alyssa Wyant | Senior Vice President-Regulatory Affairs | Female |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
Edge Therapeutics - Competitors and Related Companies
How Edge Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Edge Therapeutics
EDGE:NAS
Biotechnology
$0
SMALL cap
$0.50
(0.00%)
0.39%
since start of 2019
-0.38
PDL BioPharma
PDLI:NAS
Biotechnology
$279.23mm
SMALL cap
$2.44
(0.01%)
-0.16%
since start of 2019
7.93
Pieris Pharmaceuticals
PIRS:NAS
Biotechnology
$154.35mm
SMALL cap
$3.13
(-0.14%)
0.08%
since start of 2019
-4.05
Bioblast Pharma
ORPN:NAS
Biotechnology
$0
MICRO cap
$11.50
(0.00%)
0.69%
since start of 2019
-0.80
Plandai Biotechnology
PLPL:OTC
Food: Meat/Fish/Dairy
$0
MICRO cap
$0.00
(0.00%)
-0.82%
since start of 2019
-0.02